Is Wall Street misreading its
favorite risk metric?

For decades, the financial industry has relied on the Sharpe ratio as a benchmark for performance. It is simple, intuitive and deeply embedded in practice: higher Sharpe, better strategy.

But a new study suggests the issue is not the Sharpe ratio itself — it is how we interpret its reliability.

CAPTION: Emilio Porcu-spatial statistician, data scientist and  mathematics professor at Khalifa University IMAGE: Khalifa University

Emilio Porcu, a theoretical statistician and data scientist at Khalifa University, together with Marcos López de Prado and Vincent Zoonekynd of the Abu Dhabi Investment Authority and Nobel Laureate Robert Engle, argues that the Sharpe ratio remains a valid and meaningful tool — but only if it is understood within the correct probabilistic framework.

Financial markets, they note, do not behave like textbook models. Volatility clusters shift between calm and turbulence. Risk is time-varying, and expected returns can depend directly on that risk. Extreme events are not rare anomalies — they are part of the system.

Under these conditions, the classical statistical machinery used to assess Sharpe ratio uncertainty — typically based on stable, Gaussian assumptions — may no longer be appropriate.

“The problem is not the Sharpe ratio,” Porcu explains. “The problem is assuming that its uncertainty can be described in the same way across all market conditions.”

CAPTION: Marcos López de Prado-Professor of Practice in the mathematics department at Khalifa University and the Global Head of Quantitative Research and Development at the Abu Dhabi Investment Authority IMAGE: MIT Media Lab

“There are situations where the usual tools don’t just need adjustment,” Porcu says. “They are answering a different question altogether.”

The team proved a fundamental theorem that explicitly accounts for these features. Using GARCH-type models — widely used in finance to capture volatility dynamics — they derive closed-form expressions for the uncertainty of the Sharpe ratio when returns are driven by persistent and evolving risk.

Their key insight is that “Sharpe ratio inference is regime-dependent.”

In light-tailed environments, classical Gaussian approximations may still apply, although with important corrections reflecting volatility persistence and feedback effects. But in heavier-tailed regimes — where extreme events are more frequent and key moments may not exist — the entire statistical framework can shift.

The paper, submitted to Econometrica, has already attracted significant attention. A recent LinkedIn post discussing the work generated hundreds of comments and thousands of downloads within days.

For Marcos López de Prado, the implications are practical and immediate: “Investors often treat high Sharpe ratios as evidence of skill,” he says. “But that conclusion depends on how uncertainty is measured. Our results show precisely when classical inference is valid, when it needs correction, and when it breaks down entirely. If volatility dynamics and tail risk are ignored, Sharpe ratios can be misinterpreted — sometimes severely.”

IMAGE: Shutterstock

Rather than undermining the Sharpe ratio, the research places it on firmer ground. It shows that the metric remains meaningful, but only when its statistical context is properly specified.

The takeaway is subtle, but consequential: The question is not whether the Sharpe ratio is right or wrong.

The question is: in which probabilistic regime are you using it?

More like this: What’s chaining block chain?

The immensity of intensity

Terms like “glacial” are often applied to regions like the Antarctic. Although that might create an image of slowly changing landscapes, sometimes it’s quite the opposite.

A recent study conducted by researchers from Khalifa University shows that snow can grow or shrink daily due to sudden weather shifts.

While studying the ice close to Mawson Station in East Antarctica, scientists discovered that although the seasonal patterns of growing and shrinking sea ice is predictable, the snow on top can change quickly.

These shifts aren’t caused by seasonal changes, but by sudden weather. Extreme snowfall, strong winds or gusts of warm air can add, shift or remove snow.

Most notably, these changes can be caused by atmospheric rivers, which are large streams of moisture in the air that can simultaneously drop snow and stir up strong winds that could blow much of the snow away.

Katabatic winds (fast-moving air speeding down from the Antarctic’s high interior) can also be responsible for removing snow from the surface or disappearing it into the air.

Why does this matter?

Snow and sea ice help regulate the Earth’s climate. Understanding that the Antarctic ice system is more akin to a volatile stock market than a slow drift can help scientists improve climate models and better understand what’s coming next as Antarctic ice continues to shift.

More like this: A river runs over it

Smooth operators

Solar power is a great source of green energy, but it can also be inconsistent.

When clouds pass over or the sunlight adjusts, solar-plant electricity outputs can move up and down like a volatile stock. This can make power-grid stability complicated.

A recent study from Khalifa University suggests that these volatilities can be tempered by allowing batteries and hydrogen storage to work together.

Batteries can manage and handle quick changes in power, while extra energy can be utilized to produce hydrogen. The hydrogen is then stored and later converted back into electricity with fuel cells.

This system’s control strategy constantly monitors battery charge, hydrogen levels and efficiency to determine how to share the workload in real time.

The simulations reveal that this method reduces battery degradation by approximately 50 percent while maintaining much smoother solar power flow to the grid.

More like this: Solar panel sunscreen

Pineapples to the rescue

Yesterday’s pineapple peels could become tomorrow’s arid-region food security.

Researchers at Khalifa University recently discovered that turning discarded pineapple peels into nano-scale cellulose and injecting it into sand can supercharge the soil’s capabilities.

The team conducted tests on three types of sand and found that the nanocellulose fibers — tiny, thread-like fibers made from plants — resulted in 58 percent reduction in water permeability, a water-holding capacity increase of 32.7 percent and the ability to withstand pressure force of 0.5 megapascals.

The pressure force doesn’t sound like much but the difference between sand and living soil isn’t water, it’s how the pressure moves. This pressure is the point at which sand is no longer passive and begins to push back, making it harder for roots to grow. So remaining under .5 megapascals is key to growth.

This paper, published in the Journal of Bioresources and Bioproducts, proves that food waste can be repurposed to make desert soils more productive, contributing to food security and a circular economy.

And bonus — we get to eat more delicious pineapples.

More like this: Gift from the sea

Mapping the Emirati genome

Before scientists discovered the millions of hidden gems of the Emirati genome and before personalized medicine became the forefront of healthcare, there was a vision: the Emirati Genome Project.

For decades the Arab genome had been invisible to international databases, and this left researchers lacking insight on regional diseases.

IMAGE: UAE Year of Family

This gap was the main target for the Department of Health – Abu Dhabi, which established the Emirates Genome Council in June 2021 chaired by His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi.

The Genome Project aimed to build a complete and comprehensive genetic map of the Emirati population and advance the UAE in the field of precision medicine.

The project took its first step into light worldwide when researchers identified more than 1 billion genetic variants through analyzing almost 40,000 Emirati genomes; 38 percent of the identified variations were specific to the Emirati population.

CAPTION: Haleema Rauf

Now with over 800,000 samples collected nationwide and several global collaborations, including with Harvard Medical School to train 500 Emirati physicians in genomic medicine, it is recognized worldwide.

“This initiative is not only enhancing local capacity in Abu Dhabi but also setting a benchmark for global healthcare standards,” said Alireza Haghighi, founding director of the Harvard International Center for Genetic Disease.

Suddenly there was a new road being paved for the future of medicine, and it was all happening on home soil.


BEFORE THE BREAKTHROUGH, PREDECESSORS
AND INSPIRATION

To fully understand this milestone, we need to take a step back and recognise the roots of this effort, beyond the laboratories.

Let’s rewind to the 1990s when the idea of DNA mapping ignited the creation of the Human Genome Project, a global milestone. Later, the Human Pangenome Reference Consortium showed how powerful and important genome mapping was. It also highlighted the under-representation of non-European populations in global genomic databases.

Moving forward to the 2010s, researchers in the Middle East had come face-to-face with the absence of the Arab genomic data. This left them blind to the disease patterns and risk factors required to treat the regional population.

In 2015 there was a sudden shift when the Qatar Genome Project was launched. Alongside this initiative, the region started premarital and newborn-screening programs. These combined efforts highlighted the importance of early genetic detection and the gaps in clinical genomics that could not be ignored any longer.


This initiative is not only enhancing local capacity in Abu Dhabi but also setting a benchmark for global healthcare standards.

Alireza Haghighi, Harvard International Center for Genetic Disease


For the UAE, healthcare leaders seemed to realize the same need, with high rates of recessive genetic conditions due to consanguinity. Keeping in mind UAE’s position as a global innovation hub, the launch of the Emirati Genome Project was not just a step forward in science, but it also established itself as one of the largest population genome projects. It aimed to sequence 1 million Emirati genomes. This initiative marks a landmark in UAE’s journey into precision healthcare.

THE NEW ERA: EMIRATI DNA AT THE
FOREFRONT OF DEVELOPMENT

The Emirati Genome Project is currently one of the world’s most active population-genomics initiatives.

The UAE now has its first full telomere-to-telomere reference genome (a complete version of the Emirati genetic map). The risk of hereditary cancer can now be detected earlier than ever before through precision oncology programs. Moreover, newborn screening now identifies more than 815 treatable genetic conditions.

In this era, doctors can decide on the safest and most effective medications for their patients. This has revolutionized scientific research.

CHALLENGES FACED
AND OVERCOME

Success did not come without struggle. This may seem like a seamless operation, but it was built through years of problem-solving and careful policy development.

The biggest obstacle faced was ensuring the public’s trust and the safety of their data. A survey in 2022 showed that 73% of the population supported the program; the rest were willing to participate but hesitated due to privacy concerns. This meant a legal and technological framework was needed to safeguard the highly sensitive information. The UAE established one of the strongest genomic data-protection laws in the world. This made sure that all genetic data would be stored within national infrastructure and protected heavily.

This leads us to the next hurdle: Where would the infrastructure for processing the massive amount of genetic data come from?

This is how the M42 Centre of Excellence was established.

Today, it is the largest sequencing facility outside of the United States, and it enables industrial-scale processing that is supported by robotics.


Further partnerships with institutes like Khalifa University, Harvard Medical School International Center for Genetic Disease, SEHA and Cleveland Clinic Abu Dhabi have made possible the training and education of professionals and developing large laboratories to accomplish the groundbreaking research.

This has positioned the UAE as a global leader in precision medicine and research. The Emirati Genome Project stands as a testament to the possibilities of scientific ambition, and the discoveries are already reshaping the future of healthcare globally.

Haleema Rauf is a cell & molecular biology junior at Khalifa University.

More like this: Of mummies, mice and medical students